Alosetron is a 5-HT3 receptor antagonist that treats severe diarrhea-predominant irritable bowel syndrome (IBS-D). This educational activity focuses on the indications, mechanism of action, and contraindications associated with alosetron. Participants will also review the FDA-issued box warnings, adverse event profiles, toxicity, and critical considerations such as dosing, monitoring, and relevant drug interactions. Understanding alosetron’s pharmacological features significantly enhances healthcare professionals’ ability to tailor treatment plans to individual patient needs. Reviewing this information can help interprofessional healthcare team members deliver targeted, safe, and personalized care, improving outcomes for patients receiving alosetron therapy.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/17388
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABA - 1.0 Point; Credit Type(s): Lifelong Learning (ABA)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Adolescent Medicine, Ambulatory/Outpatient, Chemical Pathology, Gastroenterology, General Operative Anesthesia, General Pediatrics, General Surgery, GI (incl. Liver, Pancreas, Bilary), Hospital Medicine, Internal Medicine, Pain Medicine, Pediatric Gastroenterology